250
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Association between FOXP3 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis

, &
Pages 445-452 | Received 29 Dec 2014, Accepted 06 Apr 2015, Published online: 15 May 2015
 

Abstract

Objective: The aim of this study was to explore whether the FOXP3 −3279 A/C polymorphism and (GT)n microsatellite polymorphisms are associated with susceptibility to autoimmune diseases. Methods: A meta-analysis was conducted on the associations between the FOXP3 −3279 A/C polymorphism and (GT)15 and (GT)16 polymorphisms and autoimmune diseases. Results: Twenty-two comparative studies with a total of 7962 patients and 7453 controls were included in the meta-analysis. Meta-analysis revealed an association between autoimmune disease and the FOXP3 −3279 AA + AC genotype (OR = 1.480, 95% CI = 1.263–1.614, p < 1.0 × 10−9), and stratification by ethnicity indicated a significant association between the FOXP3 −3279 AA + AC genotype and autoimmune diseases in Asians (OR = 1.416, 95% CI = 1.225–1.637, p = 2.5 × 10−7) and non-Caucasians (OR = 1.432, 95% CI = 1.245–1.647, p = 7.5 × 10−8). In addition, corrected p values for multiple testing remained significant. Meta-analysis revealed no association between autoimmune disease and the FOXP3 (GT)15 allele (OR = 1.051, 95% CI = 0.933–1.183, p = 0.413). Similarly, the FOXP3 (GT)16 allele showed no associations with autoimmune disease. Conclusions: This meta-analysis indicates that the FOXP3 −3279 A/C polymorphism is associated with susceptibility to autoimmune disease in Asians and non-Caucasians.

Declaration of interest

The authors have no conflict of interest to declare.

This study was supported in part by a grant of the Korea Healthcare technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI13C2124).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.